Very low LDL‐C levels may safely provide additional clinical cardiovascular benefit: the evidence to date

BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death in Europe and increased low‐density lipoprotein cholesterol (LDL‐C) is a major contributor to CVD risk. Extensive evidence from clinical studies of statins has demonstrated a linear relationship between LDL‐C levels and CVD risk....

Descripción completa

Detalles Bibliográficos
Autores principales: McCormack, Terry, Dent, Ricardo, Blagden, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Cardiovascular
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215677/
https://www.ncbi.nlm.nih.gov/pubmed/27739167
http://dx.doi.org/10.1111/ijcp.12881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215677/
https://www.ncbi.nlm.nih.gov/pubmed/27739167
http://dx.doi.org/10.1111/ijcp.12881

Ejemplares similares